# SUCROSE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2021288
Categories: beauty, cleaning, food, industrial, pharma
Functions: Binder, Flavouring and nutrient, Fragrance, Hog Scald Agents (must be removed by subsequent cleaning operations), Humectant, Processing aids not otherwise specified, Softener and conditioner
Identifier: DTXSID2021288

> SUCROSE is used as binder / flavouring and nutrient. EPA CPDat observed this chemical in 1019 composition records across product categories including Industrial products, Construction and building materials, Pesticides. Assessed from 57 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 1019 composition records across product categories including Industrial products, Construction and building materials, Pesticides.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 1019 composition records across product categories including Industrial products, Construction and building materials, Pesticides. EPA CPDat classifies this chemical for functional uses including Humectant, Softener and conditioner, Binder.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: LOZENGE; Potency: NA
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 109 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TROCHE; Potency: NA
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTABLE, LIPOSOMAL; Maximum daily exposure: 7560 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 1950 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 970 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: 900 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 2000 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: NA
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION, LIPOSOMAL; Potency: 9.4 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 3568 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 59.8 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Maximum daily exposure: 86 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 955 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 619 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 4800 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: DROPS; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: ELIXIR; Maximum daily exposure: 18000 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Maximum daily exposure: 42596 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 31885 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION, EXTENDED RELEASE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: LIQUID; Maximum daily exposure: 37500 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: PASTILLE; Potency: 426 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 27768 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 38666 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 40017 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 70000 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 48209 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 5400 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 3750 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 46400 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4249 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 7258 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 516.42 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 295.33 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 284.54 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 145 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 119.12 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TROCHE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: WAFER; Potency: 155.2 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: SOLUTION; Potency: 35.42 %w/v
- US: inactive ingredient database — Route: RECTAL; Dosage form: SUPPOSITORY; Potency: NA
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 47.75 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 308 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 109 mg
- US: inactive ingredient database — Route: TRANSMUCOSAL; Dosage form: LOZENGE; Maximum daily exposure: 1255 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 48 active drug products and 56 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.
- US: observed in branded food ingredient statements — Observed in 5 USDA branded foods including 1.5OZ LITEHOUSE CHUNKY BLUE CHEESE DRESSING, 1.5OZ LITEHOUSE JALAPENO RANCH DRESSING, 1.5oz LITEHOUSE CAESAR DRESSING.

_Assessed by Greenveil._